Back to Results
First PageMeta Content
Medicine / Pharmacology / Bristol-Myers Squibb / HIV/AIDS / Organofluorides / Tenofovir/emtricitabine / Emtricitabine/tenofovir/efavirenz / Tenofovir / Emtricitabine / Gilead Sciences / Fixed dose combination / Chemistry


Document Date: 2014-04-29 19:53:59

Open Document

File Size: 73,85 KB

Share Result on Facebook

City

ARTG / City / Foster City / /

Company

Gilead Scien nces Inc. / Gilead Sciencees Pty Ltd / Gilead G Scien nces Inc. / Sciences LLC. / Sciencess Inc. / /

Country

United States / Australia / United Kingdom / /

Currency

ZAR / /

/

Event

FDA Phase / /

IndustryTerm

HIV treatment / marketed products / /

MedicalCondition

DF / cancer / HIV / V Infection / AIDS / infection / /

MedicalTreatment

Drug Therapy / /

Organization

National Science Foundation / Federal Trade Commission / ded / /

Person

Bill W Whittaker / Julia Renaud / Na / Alexandra A McDonald / /

Position

cob / Governor / spokesperson / /

Product

efavirenz / EMTRIVA / TRUVADA / inh / ATRIPLA / STRIBILD® / EV VIPLERA® / V-1 / /

ProvinceOrState

Prince Edward Island / /

RadioStation

Bill W Whittaker AM / /

Technology

pdf / /

URL

www.stribild.com/hcp/virologic-respon / www.ebss.tga.gov.au/se / www.tga.govv.au/pdf/auspa / www.stribild.com/hcp / /

SocialTag